405P: Targeting AURKA, nuclear factor erythroid-2-related factor 2 (Nrf2), and phosphoserine aminotransferase 1 (PSAT1) in KRASG12C-mutant lung adenocarcinoma
Ming-Yi Zhou(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), R. Rosell(Instituto Oncológico Dr. Rosell), Daniel González(University of North Carolina at Chapel Hill), Jianzhong Zhang(Chinese Academy of Sciences), Feng Yan(Jiangsu Cancer Hospital), Feng Zhou(Wuhan University), J. González(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Jordi Codony‐Servat(Hospital Universitario Dexeus), Yang Wang(Chengdu Technological University), K. Valencia(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol)
Cited by 0
Related Papers
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232